RAP Therapeutics acquisition by GSK

Julie covers GSK's $2.2 billion tender offer for RAP Therapeutics and the $58 per share deal details.

Play episode from 04:57

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!